On the fly News and insights, exclusive to thefly.com

TGT

Target

$255.58 /

+1.89 (+0.75%)

, ECOL

US Ecology

$30.00 /

-1.23 (-3.94%)

09:54
10/19/21
10/19
09:54
10/19/21
09:54

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Target (TGT) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Kate McShane saying Target has gained share across all categories over the past 18 months supporting double digit sales growth and "outsized" operating income growth, but the pace of its revenue growth should slow into 2022 to be in-line with historical levels. 2. US Ecology (ECOL) downgraded to Hold from Buy at Stifel with analyst Michael Hoffman saying 2021 has "proven less predictable" for waste services companies and another cut in guidance possible for US Ecology is possible. 3. Williams (WMB) downgraded to Peer Perform from Outperform at Wolfe Research with analyst Alex Kania citing valuation for the downgrade with the target reflecting less upside potential. 4. Marriott (MAR) downgraded to In Line from Outperform at Evercore ISI with analyst Rich Hightower calling his change in rating "simply a valuation call" after hotel stocks' "nice outperformance streak" over the past 30 to 60 days. 5. Akero Therapeutics (AKRO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Michael Ulz saying while he believes efruxifermen has "a differentiated, best-in-class profile," negative investor sentiment on the nonalcoholic steatohepatitis, space and a lack of near-term catalysts keep him on the sidelines. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TGT

Target

$255.58 /

+1.89 (+0.75%)

ECOL

US Ecology

$30.00 /

-1.23 (-3.94%)

WMB

Williams

$29.03 /

-0.26 (-0.89%)

MAR

Marriott

$157.20 /

-2.01 (-1.26%)

AKRO

Akero Therapeutics

$20.60 /

-0.83 (-3.87%)

  • 02

    Nov

  • 03

    Nov

  • 05

    Nov

  • 17

    Nov

TGT Target
$255.58 /

+1.89 (+0.75%)

10/18/21 Goldman Sachs
Target downgraded to Buy from Conviction Buy at Goldman Sachs
10/06/21 Morgan Stanley
Affirm relationship with Target not new, says Morgan Stanley
08/26/21 Tigress Financial
Target shares to hit $320 within 12 months, says Tigress Financial
08/19/21 Jefferies
Target price target raised to $260 from $235 at Jefferies
ECOL US Ecology
$30.00 /

-1.23 (-3.94%)

10/19/21 Stifel
US Ecology downgraded to Hold from Buy at Stifel
10/06/21 BMO Capital
US Ecology price target lowered to $38 from $40 at BMO Capital
09/17/21 Stifel
US Ecology could be worth over $2B to PE or strategic buyer, says Stifel
03/10/21 Kansas City Capital
US Ecology upgraded to Outperform from Perform at Kansas City Capital
WMB Williams
$29.03 /

-0.26 (-0.89%)

10/19/21 Wolfe Research
Williams downgraded to Peer Perform from Outperform at Wolfe Research
09/28/21 BofA
BofA reinstates coverage of U.S. Midstream sector with six buys, four sells
09/28/21 BofA
Williams reinstated with a Buy at BofA
05/17/21 Argus
Williams upgraded to Buy from Hold at Argus
MAR Marriott
$157.20 /

-2.01 (-1.26%)

10/19/21 Evercore ISI
Marriott downgraded to In Line on valuation at Evercore ISI
10/18/21 Evercore ISI
Marriott downgraded to In Line from Outperform at Evercore ISI
10/05/21 Loop Capital
Hyatt initiated with a Hold at Loop Capital
10/05/21 Loop Capital
Marriott initiated with a Hold at Loop Capital
AKRO Akero Therapeutics
$20.60 /

-0.83 (-3.87%)

10/19/21 Morgan Stanley
Akero Therapeutics assumed at Equal Weight from Overweight at Morgan Stanley
09/10/21 BofA
Akero Therapeutics initiated with a Buy at BofA
08/16/21 H.C. Wainwright
Akero Therapeutics price target lowered to $64 from $68 at H.C. Wainwright
03/23/21 H.C. Wainwright
Akero Therapeutics price target raised to $68 from $61 at H.C. Wainwright

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.